Proteomedix Agrees to Issue Labcorp Exclusive License for Proclarix Blood Test to Detect Prostate Cancer
Labcorp Plans to Develop and Commercialize the Innovative Prostate Cancer Liquid Biopsy Test in the U.S. Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced
Source: finanznachrichten.de